Regarding risk genes, genome-wide association studies have been instrumental in identifying genes linked to an altered risk of developing tauopathies such as AD or FTLD-tau (Ferrari et al, 2014; Cuyvers & Sleegers, 2016; Gan et al, 2018). Here, MAPT is linked to Alzheimer disease.